United States · 
Who invested in Be Biopharma?
Be Biopharma's investors include Atlas Venture, RA Capital Management, ARCH Venture Partners and Longwood Fund.
United States · Series C startup
Who invested in Be Biopharma
Funding summaryUpdated 26 Oct 2026
$92Mraised across 1 round since 2025, from 1 source
- Latest round
- Series C, $92MJan 2025
- Investors
- 4
The rounds
- Jan 2025
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 2 firms list Be Biopharma as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Be Biopharma
How much has Be Biopharma raised?
Be Biopharma has raised $92M across 1 round since 2025.
When did Be Biopharma last raise?
Be Biopharma's most recent round was a Series C of $92M in Jan 2025.
What was Be Biopharma's biggest round?
Its most recent round, $92M in Jan 2025, is also its largest on record.
Who backed Be Biopharma first?
Be Biopharma's first round on record, in Jan 2025, was backed by Atlas Venture, RA Capital Management and ARCH Venture Partners and 1 others.
What stage is Be Biopharma at?
Be Biopharma's latest named round is a Series C, in Jan 2025.
Where is Be Biopharma based?
Be Biopharma is based in the United States.
Companies like Be Biopharma
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.